Skip to main content
Caplight Logo









Arvo

Arvo

Private
São PauloHealthcare & Life Scienceshttps://www.arvo.com.br/

Last Round

Series A

Sep 17, 2025

Total Funding Raised

$24.5M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Arvo is a health technology company that provides a platform for healthcare and health insurance operators to prevent fraud, errors, and waste in medical billing and claims.

Sector

Healthcare & Life Sciences

Verticals

InsurTech, Healthcare Analytics, Medical AI, Revenue Cycle

Business Model

B2B

Customer Profile

Subscription SaaS, Usage-Based SaaS

AI Layer

Application

Keywords

medical claims auditinghealthcare fraud detectionclaims processinghealth techinsurtechAI claims auditbilling validationhealthcare analyticsrevenue cycle managementRCMhealthcare waste reductionprocedure authorizationSaaS platformAI agentsclaims integrity

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Arvo Comparables

Compare Arvo with similar companies based on industry and business-model similarity.

Arvo comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Carefy
86%
B3 S.A. – Brasil, Bolsa, Balcão
81%
Alaffia Health
77%

Arvo Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ASep 17, 2025
SeedSep 4, 2024

Key People

Founding team and executive leadership

Fabricio Valadão

Founder CEO

Founding Team

David Robert

Chief Technology Officer

Executive Team

Arvo Investors

Notable investors and investment history

Arvo investors
InvestorRounds
Latitud VenturesSeed
Preface VenturesSeed
Base10 PartnersSeries A
CanarySeries A, Seed
Actions CapitalSeries A, Seed
KaszekSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 18, 2026

    Grew 28% QoQ, from 93 to 119 employees.

  • Mar 18, 2026

    Grew 20% QoQ, from 92 to 110 employees.

Recent news

Latest coverage and updates

  • hiresSep 18, 2026

    Arvo hired Rita Sobroza as medical audit manager on Sep 18th '26.

Arvo Filings

Explore SEC and related filing metadata, where available.

Arvo filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Arvo's valuation, stock price, and market status.

Is Arvo a public or private company?

Arvo is a private company.

What is the current stock price of Arvo?

Arvo is a private company with no public stock price. No recent secondary market data is available.

How much is Arvo worth (valuation)?

Valuation information for Arvo is not publicly available.

Can I buy Arvo stock?

Arvo shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Arvo's last funding round?

Arvo's most recent funding round was Series A on September 17, 2025.

Who are the main investors in Arvo?

Key investors in Arvo include Base10 Partners, Canary, Actions Capital, Kaszek.

Will Arvo IPO soon?

No public IPO plans have been announced for Arvo.

How can I track Arvo secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Arvo's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSão Paulo
Employee Range114
Year Founded2022
Last FundingSep 17, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?